Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Allergy Diagnostics and Therapeutics Market: By Product: Instruments, Consumables, Services; By Allergen Type: Food, Inhaled, Drug, Others; By End Use; By Diagnostic Tests; By Drug Class; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Allergy Diagnostics & Therapeutics Market Outlook

The global allergy diagnostics & therapeutics market was estimated at USD 34.1 billion in 2020 and is projected to increase further over the forecast period of 2023-2028 at a CAGR of 6.5%.

 

Rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, are anticipated to drive the industry growth of the allergy diagnostics & therapeutics in the coming years.

 

Global Allergy Diagnostics and Therapeutics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Segmentation

The allergy diagnostics & therapeutics market can be divided on the basis of segments like product, allergen type, end-use, diagnostic tests, and drug class. The industry can be broadly categorised on the basis of product into:

 

Global Allergy Diagnostics and Therapeutics Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Instruments
  • Consumables
  • Services

The industry can be categorised on the basis of allergen type into:

  • Food
  • Inhaled
  • Drug
  • Others

The industry can be divided based on end-uses into:

  • Diagnostics labs
  • Hospitals
  • Academic Research Institutes

The industry can be divided on the basis of diagnostic tests as:

  • In-Vivo
  • Skin Prick Test
  • Intradermal
  • Patch Test
  • In-Vitro

The industry can be segmented based on drug class as:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Autoinjectable Epinephrine
  • Immunotherapy

The EMR report looks into the regional markets of allergy diagnostics & therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.

 

Global Allergy Diagnostics and Therapeutics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The growth of the allergy diagnostics & therapeutics industry is expected to be driven by a number of factors, such as the high incidence and high economic burden of allergic diseases, increased healthcare spending, and increased access to medical insurance in the United States. Within allergy testing, factors such as widespread availability and high consumption of assay kits are expected to drive the development of this segment in the following years. The category of inhaled allergens is projected to represent the largest share of the market for allergy diagnostics in the forecast period. Increasing environmental pollution is one of the main factors driving the market growth. Growing investments, rising research activities, and increasing acceptance from the United States for allergy treatment via medical insurance are the key factors accelerating the market growth.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global allergy diagnostics & therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • GlaxoSmithKline plc
  • Stallergenes Greer Ltd
  • Hitachi Chemical Co., Ltd
  • Omega Diagnostics Group PLC
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare GmbH
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Allergen Type, End Use, Diagnostic Tests, Drug Class, Region
Breakup by Product Instruments, Consumables, Services
Breakup by Allergen Type Food, Inhaled, Drug, Others
Breakup by End Use Diagnostics labs, Hospitals, Academic Research Institutes
Breakup by Diagnostic Tests In-Vivo, Skin Prick Test, Intradermal, Patch Test, In-Vitro
Breakup by Drug Class Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Autoinjectable Epinephrine, Immunotherapy
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered GlaxoSmithKline plc, Stallergenes Greer Ltd, Hitachi Chemical Co., Ltd, Omega Diagnostics Group PLC, bioMérieux SA, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Allergy Diagnostics and Therapeutics Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Allergy Diagnostics and Therapeutics Historical Market (2018-2022) 
    8.3    Global Allergy Diagnostics and Therapeutics Market Forecast (2023-2028)
    8.4    Global Allergy Diagnostics and Therapeutics Market by Product
        8.4.1    Instruments
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Consumables
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Services
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
    8.5    Global Allergy Diagnostics and Therapeutics Market by Allergen Type
        8.5.1    Food
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Inhaled
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Drug
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Others
    8.6    Global Allergy Diagnostics and Therapeutics Market by End Use
        8.6.1    Diagnostics Labs
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Hospitals
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Academic Research Institutes
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
    8.7    Global Allergy Diagnostics and Therapeutics Market by Diagnostic Tests
        8.7.1    In-Vivo
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022)
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Skin Prick Test
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022)
            8.7.2.3    Forecast Trend (2023-2028)
        8.7.3    Intradermal
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2022)
            8.7.3.3    Forecast Trend (2023-2028)
        8.7.4    Patch Test
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2018-2022)
            8.7.4.3    Forecast Trend (2023-2028)
        8.7.5    In-Vitro
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2018-2022)
            8.7.5.3    Forecast Trend (2023-2028)
    8.8    Global Allergy Diagnostics and Therapeutics Market by Drug Class
        8.8.1    Antihistamines
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2018-2022)
            8.8.1.3    Forecast Trend (2023-2028)
        8.8.2    Decongestants
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2018-2022)
            8.8.2.3    Forecast Trend (2023-2028)
        8.8.3    Corticosteroids
            8.8.3.1    Market Share
            8.8.3.2    Historical Trend (2018-2022)
            8.8.3.3    Forecast Trend (2023-2028)
        8.8.4    Mast Cell Stabilisers
            8.8.4.1    Market Share
            8.8.4.2    Historical Trend (2018-2022)
            8.8.4.3    Forecast Trend (2023-2028)
        8.8.5    Leukotriene Inhibitors
            8.8.5.1    Market Share
            8.8.5.2    Historical Trend (2018-2022)
            8.8.5.3    Forecast Trend (2023-2028)
        8.8.6    Nasal Anticholinergics
            8.8.6.1    Market Share
            8.8.6.2    Historical Trend (2018-2022)
            8.8.6.3    Forecast Trend (2023-2028)
        8.8.7    Immunomodulators
            8.8.7.1    Market Share
            8.8.7.2    Historical Trend (2018-2022)
            8.8.7.3    Forecast Trend (2023-2028)
        8.8.8    Autoinjectable Epinephrine
            8.8.8.1    Market Share
            8.8.8.2    Historical Trend (2018-2022)
            8.8.8.3    Forecast Trend (2023-2028)
        8.8.9    Immunotherapy
            8.8.9.1    Market Share
            8.8.9.2    Historical Trend (2018-2022)
            8.8.9.3    Forecast Trend (2023-2028)
    8.9    Global Allergy Diagnostics and Therapeutics Market by Region
        8.9.1    Market Share
            8.9.1.1    North America
            8.9.1.2    Europe
            8.9.1.3    Asia Pacific
            8.9.1.4    Latin America
            8.9.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2018-2022)
        9.1.2    Forecast Trend (2023-2028)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2018-2022)
        9.2.2    Forecast Trend (2023-2028)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Spain
            9.2.3.6    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2018-2022)
        9.3.2    Forecast Trend (2023-2028)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2018-2022)
        9.4.2    Forecast Trend (2023-2028)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2018-2022)
        9.5.2    Forecast Trend (2023-2028)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    GlaxoSmithKline plc
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Stallergenes Greer Ltd
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Hitachi Chemical Co., Ltd
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Omega Diagnostics Group PLC
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    bioMérieux SA
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Thermo Fisher Scientific Inc.
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Siemens Healthcare GmbH
            11.2.7.1    Company Overview
            11.2.7.2    Product Portfolio
            11.2.7.3    Demographic Reach and Achievements
            11.2.7.4    Certifications
        11.2.8    Others
12    Industry Events and Developments


List of Key Figures and Tables

1.    Global Allergy Diagnostics and Therapeutics Market: Key Industry Highlights, 2018 and 2028
2.    Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Product (USD Billion), 2018-2022
3.    Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Product (USD Billion), 2023-2028
4.    Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Allergen Type (USD Billion), 2018-2022
5.    Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Allergen Type (USD Billion), 2023-2028
6.    Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by End Use (USD Billion), 2018-2022
7.    Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by End Use (USD Billion), 2023-2028
8.    Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Diagnostic Tests (USD Billion), 2018-2022
9.    Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Diagnostic Tests (USD Billion), 2023-2028
10.    Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Drug Class (USD Billion), 2018-2022
11.    Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Drug Class (USD Billion), 2023-2028
12.    Global Allergy Diagnostics and Therapeutics Historical Market: Breakup by Region (USD Billion), 2018-2022
13.    Global Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Region (USD Billion), 2023-2028
14.    North America Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    North America Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Europe Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Europe Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Asia Pacific Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
19.    Asia Pacific Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
20.    Latin America Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
21.    Latin America Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
22.    Middle East and Africa Allergy Diagnostics and Therapeutics Historical Market: Breakup by Country (USD Billion), 2018-2022
23.    Middle East and Africa Allergy Diagnostics and Therapeutics Market Forecast: Breakup by Country (USD Billion), 2023-2028
24.    Global Allergy Diagnostics and Therapeutics Market Structure

Key Questions Answered in the Report

The global allergy diagnostics and therapeutics market attained a value of nearly USD 34.1 billion in 2020.

The market is projected to grow at a CAGR of 6.5% between 2021 and 2026.

The major drivers of the market include rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis, growing investments, and the rising research activities.

The increasing acceptance from the United States for allergy treatment via medical insurance are the key industry trends propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The product type in the market includes instruments, consumables, and services.

Allergens can be divided into food, inhaled, and drug, among others. Inhaled allergen is the dominant type of allergy diagnostics and therapeutics in the industry.

End uses can be divided into diagnostics labs, hospitals, and academic research institutes.

In-vivo, skin prick test, intradermal, patch test, and in-vitro are the major diagnostic tests in this industry.

The major players in the industry are GlaxoSmithKline plc, Stallergenes Greer Ltd, Hitachi Chemical Co., Ltd, Omega Diagnostics Group PLC, bioMérieux SA, Thermo Fisher Scientific Inc., and Siemens Healthcare GmbH, among others.

Analyst Review

The global allergy diagnostics and therapeutics market attained a value of USD 34.1 billion in 2020, driven by the rising incidences of allergic diseases, coupled with high demand for blood tests for in vitro diagnosis. Aided by growing investments, rising research activities, and increasing acceptance from the United States for allergy treatment via medical insurance, the market is expected to witness to further grow at a CAGR of 6.5% in the forecast period of 2023-2028.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The product type in the market includes instruments, consumables, and services. Based on its allergen type, the allergy diagnostics and therapeutics industry can be segmented into food, inhaled, drug, among others, with inhaled allergen accounting for the largest market share. In-vivo, skin prick test, intradermal, patch test, in-vitro are the major diagnostic tests in this industry. End uses can be divided into diagnostics labs, hospitals, and academic research institutes. The major regional markets for allergy diagnostics and therapeutics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include GlaxoSmithKline plc, Stallergenes Greer Ltd, Hitachi Chemical Co., Ltd, Omega Diagnostics Group PLC, bioMérieux SA, Thermo Fisher Scientific Inc., and Siemens Healthcare GmbH, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER